Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4041)
All Articles published online
|
Sep 14, 2009 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Mabe K, Takahashi M, Oizumi H, Tsukuma H, Shibata A, Fukase K, Matsuda T, Takeda H, Kawata S. Does |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i34/4290.htm |
| Number | Citing Articles |
| 1 |
Yi-Chia Lee, Tsung-Hsien Chiang, Chu-Kuang Chou, Yu-Kang Tu, Wei-Chih Liao, Ming-Shiang Wu, David Y. Graham. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology 2016; 150(5): 1113 doi: 10.1053/j.gastro.2016.01.028
|
| 2 |
Francisco Buitrago Ramírez, Cristina Gato Núñez, Manuel Tejero Mas, Nuria Rivera Jiménez, Francisco Luis Pérez Caballero. Criterios para la erradicación de Helicobacter pylori. FMC - Formación Médica Continuada en Atención Primaria 2018; 25(1): 43 doi: 10.1016/j.fmc.2017.03.009
|
| 3 |
Katsuhiro Mabe, Kazuhiko Inoue, Tomoari Kamada, Katsuaki Kato, Mototsugu Kato, Ken Haruma. Endoscopic screening for gastric cancer in Japan: Current status and future perspectives. Digestive Endoscopy 2022; 34(3): 412 doi: 10.1111/den.14063
|
| 4 |
Il Ju Choi. Current evidence of effects ofHelicobacter pylorieradication on prevention of gastric cancer. The Korean Journal of Internal Medicine 2013; 28(5): 525 doi: 10.3904/kjim.2013.28.5.525
|
| 5 |
Natalya N. Dekhnich, Nataly V. Ivanchik, Roman S. Kozlov, A.V. Alimov, A.S. Steshits, P.P. Kirsov. Antimicrobial resistance of Helicobacter pylori in Smolensk. Clinical Microbiology and Antimicrobial Chemotherapy 2018; 20(1): 42 doi: 10.36488/cmac.2018.1.42-48
|
| 6 |
Yingsong Lin, Sayo Kawai, Tae Sasakabe, Chisato Nagata, Mariko Naito, Keitaro Tanaka, Yumi Sugawara, Tetsuya Mizoue, Norie Sawada, Keitaro Matsuo, Tetsuhisa Kitamura, Mai Utada, Hidemi Ito, Taichi Shimazu, Shogo Kikuchi, Manami Inoue. Effects ofHelicobacter pylorieradication on gastric cancer incidence in the Japanese population: a systematic evidence review. Japanese Journal of Clinical Oncology 2021; 51(7): 1158 doi: 10.1093/jjco/hyab055
|
| 7 |
Alexander C. Ford, Anthony T. R. Axon. Epidemiology of Helicobacter pylori infection and Public Health Implications. Helicobacter 2010; 15(s1): 1 doi: 10.1111/j.1523-5378.2010.00779.x
|
| 8 |
Kentaro Sugano. Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis. Gastric Cancer 2019; 22(3): 435 doi: 10.1007/s10120-018-0876-0
|
| 9 |
Yi‐Chia Lee, Jaw‐Town Lin. Screening and treating Helicobacter pylori infection for gastric cancer prevention on the population level. Journal of Gastroenterology and Hepatology 2017; 32(6): 1160 doi: 10.1111/jgh.13726
|
| 10 |
Natalya N. Dekhnich, A.A. Tryapyshko, Ivan V. Trushin, Alexey Yu. Kuzmenkov, Roman S. Kozlov. Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of Helicobacter pylori infection in adult patients. Clinical Microbiology and Antimicrobial Chemotherapy 2020; 22(2): 119 doi: 10.36488/cmac.2020.2.119-127
|
| 11 |
Natalya N. Dekhnich, A.A. Tryapyshko, Ivan V. Trushin, Alexey Yu. Kuzmenkov, Roman S. Kozlov. Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of Helicobacter pylori infection in adult patients. Clinical Microbiology and Antimicrobial Chemotherapy 2020; 22(2): 119 doi: 10.36488/cmac.2020.2.119-127
|
| 12 |
Francisco Buitrago Ramírez, Eloísa Rodríguez Torres, Javier Alejandre Carmona. Criterios actuales para la erradicación de Helicobacter pylori. FMC - Formación Médica Continuada en Atención Primaria 2010; 17(3): 158 doi: 10.1016/S1134-2072(10)70063-3
|
| 13 |
Satoki Shichijo, Yoshihiro Hirata. Characteristics and predictors of gastric cancer after <i>Helicobacter pylori</i> eradication. World Journal of Gastroenterology 2018; 24(20): 2163-2172 doi: 10.3748/wjg.v24.i20.2163
|
| 14 |
M. Kato, M. Asaka. Recent Knowledge of the Relationship Between Helicobacter pylori and Gastric Cancer and Recent Progress of Gastroendoscopic Diagnosis and Treatment for Gastric Cancer. Japanese Journal of Clinical Oncology 2010; 40(9): 828 doi: 10.1093/jjco/hyq119
|
| 15 |
Bruna Maria Roesler, Sandra Cecília Botelho Costa, José Murilo Robilotta Zeitune. Eradication Treatment of Helicobacter pylori Infection: Its Importance and Possible Relationship in Preventing the Development of Gastric Cancer. ISRN Gastroenterology 2012; 2012: 1 doi: 10.5402/2012/935410
|
| 16 |
Tamaki Ikuse, Yo Aoyagi, Naho Obayashi, Keisuke Jimbo, Takahiro Kudo, Yoshikazu Ohtsuka, Thomas G. Blanchard, Steven J. Czinn, Toshiaki Shimizu. Antibiotic Resistance of <i>Helicobacter pylori</i> and Eradication Rate in Japanese Pediatric Patients. Advances in Microbiology 2017; 7(04): 241 doi: 10.4236/aim.2017.74020
|
| 17 |
Fujiao Duan, Chunhua Song, Jintao Zhang, Peng Wang, Hua Ye, Liping Dai, Jianying Zhang, Kaijuan Wang. Evaluation of the Epidemiologic Efficacy of EradicatingHelicobacter pylorion Development of Gastric Cancer. Epidemiologic Reviews 2019; 41(1): 97 doi: 10.1093/epirev/mxz006
|
| 18 |
Satoki Shichijo, Yoshihiro Hirata, Ryota Niikura, Yoku Hayakawa, Atsuo Yamada, Tetsuo Ushiku, Masashi Fukayama, Kazuhiko Koike. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointestinal Endoscopy 2016; 84(4): 618 doi: 10.1016/j.gie.2016.03.791
|
| 19 |
Genki Mori, Takeshi Nakajima, Kiyoshi Asada, Taichi Shimazu, Nobutake Yamamichi, Takao Maekita, Chizu Yokoi, Mitsuhiro Fujishiro, Takuji Gotoda, Masao Ichinose, Toshikazu Ushijima, Ichiro Oda. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan. Gastric Cancer 2016; 19(3): 911 doi: 10.1007/s10120-015-0544-6
|
| 20 |
Shuichi Miyamoto, Yoshiyuki Watanabe, Ritsuko Oikawa, Shoko Ono, Katsuhiro Mabe, Takahiko Kudo, Hiroyuki Yamamoto, Fumio Itoh, Mototsugu Kato, Naoya Sakamoto. Analysis of Helicobacter pylori genotypes in clinical gastric wash samples. Tumor Biology 2016; 37(8): 10123 doi: 10.1007/s13277-016-4886-4
|
| 21 |
Natalia Dekhnich, Natalie Ivanchik, Roman Kozlov, Alexander Alimov, Andrey Steshits, Pavel Kirsov, Krunal Pandav. Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation. Helicobacter 2018; 23(6) doi: 10.1111/hel.12545
|
| 22 |
Hajime Teshima, Takahiro Kotachi, Toshio Kuwai, Akiyoshi Tsuboi, Hidenori Tanaka, Ken Yamashita, Hidehiko Takigawa, Yoshihiro Kishida, Yuji Urabe, Shiro Oka. Clinicopathologic Features of Early Gastric Cancer after Helicobacter pylori Eradication in Japanese Patients: Comparative Study between Early (<10 Years) and Late (>10 Years) Onset. Cancers 2024; 16(18): 3154 doi: 10.3390/cancers16183154
|
| 23 |
Jin Su Kim, Woo Chul Chung, Kang-Moon Lee, Chang Nyol Paik, Kyeong Soo Lee, Hye Ji Kim, Young Wook Kim, Ji Han Jung, Seung June Noh, Yun Kyung Lee. Association between Genetic Instability andHelicobacter pyloriInfection in Gastric Epithelial Dysplasia. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/360929
|
| 24 |
Snežana Živković-Perišić. Helicobacter pylori and gastric cancer. Hospital Pharmacology - International Multidisciplinary Journal 2020; 7(3): 954 doi: 10.5937/hpimj2003954Z
|
| 25 |
M. Kato, M. Asaka. Recent Development of Gastric Cancer Prevention. Japanese Journal of Clinical Oncology 2012; 42(11): 987 doi: 10.1093/jjco/hys151
|
| 26 |
Eva Doorakkers, Jesper Lagergren, Lars Engstrand, Nele Brusselaers. Eradication ofHelicobacter pyloriand Gastric Cancer: A Systematic Review and Meta-analysis of Cohort Studies. Journal of the National Cancer Institute 2016; 108(9): djw132 doi: 10.1093/jnci/djw132
|
| 27 |
Yi-Fan Lu, Bin Lyu. Current situation and prospect of artificial intelligence application in endoscopic diagnosis of <i>Helicobacter pylori</i> infection. Artificial Intelligence in Gastrointestinal Endoscopy 2021; 2(3): 50-62 doi: 10.37126/aige.v2.i3.50
Abstract(853) |
Core Tip(669) |
Full Article(HTML)(2430)
|
Full Article (PDF)-700K(234)
|
Full Article (Word)-134K(162)
|
Audio-517K(4)
|
Peer-Review Report-201K(151)
|
Answering Reviewers-65K(127)
|
Times Cited (0)
|
Total Visits (8129)
|
Open
|
| 28 |
Alexander C Ford, David Forman, Richard Hunt, Yuhong Yuan, Paul Moayyedi, Paul Moayyedi. Cochrane Database of Systematic Reviews. 2015; doi: 10.1002/14651858.CD005583.pub2
|
| 29 |
Eva Doorakkers, Jesper Lagergren, Lars Engstrand, Nele Brusselaers. Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population. Gut 2018; 67(12): 2092 doi: 10.1136/gutjnl-2017-315363
|
| 30 |
Shinji Yoshii, Katsuhiro Mabe, Keiko Watano, Masayoshi Ohno, Mio Matsumoto, Shoko Ono, Takahiko Kudo, Masanori Nojima, Mototsugu Kato, Naoya Sakamoto. Validity of endoscopic features for the diagnosis ofHelicobacter pyloriinfection status based on the Kyoto classification of gastritis. Digestive Endoscopy 2020; 32(1): 74 doi: 10.1111/den.13486
|
| 31 |
Mitsushige Sugimoto, Masaki Murata, Yoshio Yamaoka. Chemoprevention of gastric cancer development after <i>Helicobacter pylori</i> eradication therapy in an East Asian population: Meta-analysis. World Journal of Gastroenterology 2020; 26(15): 1820-1840 doi: 10.3748/wjg.v26.i15.1820
|
| 32 |
Toshihisa Takeuchi, Kazuhide Higuchi. Endoscopic Detection of Gastric Carcinoma After Helicobacter pylori Eradication: More Difficult or Just Hype?. Digestive Diseases and Sciences 2016; 61(6): 1422 doi: 10.1007/s10620-016-4106-5
|
| 33 |
Akiko Saka, Kazuyoshi Yagi, Satoshi Nimura. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric Cancer 2016; 19(2): 524 doi: 10.1007/s10120-015-0479-y
|
| 34 |
Yuji Maehata, Shotaro Nakamura, Motohiro Esaki, Fumie Ikeda, Tomohiko Moriyama, Risa Hida, Ema Washio, Junji Umeno, Minako Hirahashi, Takanari Kitazono, Takayuki Matsumoto. Characteristics of Primary and Metachronous Gastric Cancers Discovered after Helicobacter pylori Eradication: A Multicenter Propensity Score-Matched Study. Gut and Liver 2017; 11(5): 628 doi: 10.5009/gnl16357
|
| 35 |
Tsung-Hsien Chiang, Hsiu-Chi Cheng, Shu-Lin Chuang, Yi-Ru Chen, Yu-Hsin Hsu, Tsui-Hsia Hsu, Li-Ju Lin, Yu-Wen Lin, Chia-Hsiang Chu, Ming-Shiang Wu, Yi-Chia Lee. Mass screening and eradication of Helicobacter pylori as the policy recommendations for gastric cancer prevention. Journal of the Formosan Medical Association 2022; 121(12): 2378 doi: 10.1016/j.jfma.2022.08.012
|
| 36 |
Hideyuki Ubukata, Hiroyuki Nagata, Takanobu Tabuchi, Satoru Konishi, Teruhiko Kasuga, Takafumi Tabuchi. Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer. Gastric Cancer 2011; 14(1): 4 doi: 10.1007/s10120-011-0005-9
|
| 37 |
Tamaki Ikuse, Thomas G. Blanchard, Steven J. Czinn. Molecular Mechanisms of Inflammation: Induction, Resolution and Escape by Helicobacter pylori. Current Topics in Microbiology and Immunology 2019; 421: 1 doi: 10.1007/978-3-030-15138-6_1
|
| 38 |
Alexander C Ford, Yuhong Yuan, David Forman, Richard Hunt, Paul Moayyedi. Helicobacter pylorieradication for the prevention of gastric neoplasia. Cochrane Database of Systematic Reviews 2020; doi: 10.1002/14651858.CD005583.pub3
|
| 39 |
Masaaki Kobayashi, Satoru Hashimoto, Ken Nishikura, Ken-ichi Mizuno, Manabu Takeuchi, Yuichi Sato, Yoichi Ajioka, Yutaka Aoyagi. Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication. Journal of Gastroenterology 2013; 48(12): 1332 doi: 10.1007/s00535-013-0764-7
|
| 40 |
Xinyue Luo, Shaochong Qi, Mo Chen, Tao Gan, Xiuhe Lv, Jinlin Yang, Kai Deng. Maintaining H. pylori Negativity After Eradication Can Consolidate Its Benefit in Gastric Cancer Prevention: A Meta-Analysis. Clinical and Translational Gastroenterology 2024; 15(8): e00742 doi: 10.14309/ctg.0000000000000742
|
| 41 |
VINCENZA CONTEDUCA, DOMENICO SANSONNO, GIANFRANCO LAULETTA, SABINO RUSSI, GIUSEPPE INGRAVALLO, FRANCO DAMMACCO. H. pylori infection and gastric cancer: State of the art. International Journal of Oncology 2013; 42(1): 5 doi: 10.3892/ijo.2012.1701
|
| 42 |
Yoshihiro Hirata, Takako Serizawa, Satoki Shichijo, Nobumi Suzuki, Kosuke Sakitani, Yoku Hayakawa, Atsuo Yamada, Kazuhiko Koike. Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen. International Journal of Infectious Diseases 2016; 51: 66 doi: 10.1016/j.ijid.2016.08.019
|
| 43 |
Peter MALFERTHEINER, Jan BORNSCHEIN, Michael SELGRAD. Role of Helicobacter pylori infection in gastric cancer pathogenesis: A chance for prevention. Journal of Digestive Diseases 2010; 11(1): 2 doi: 10.1111/j.1751-2980.2009.00408.x
|